Skip to main content
SpringerLink
Log in

Ion channel modulation as a drug discovery target in inflammatory diseases

  • Meeting Report
  • Published:
Inflammation Research Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Author information

Authors and Affiliations

  1. Central Research Division, Pfizer Inc., 558 Eastern Point Road, 06340, Groton, CT, USA

    D. C. Hanson

  2. Amgen Inc., 3200 Walnut Street, 80301, Boulder, CO, USA

    K. Koch

Authors
  1. D. C. Hanson
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. K. Koch
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hanson, D.C., Koch, K. Ion channel modulation as a drug discovery target in inflammatory diseases. Inflamm Res 45, 435–437 (1996). https://doi.org/10.1007/BF02252312

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02252312

Keywords

Search

Navigation